SD

Soumyabrata Das

Active Director Director DIN 03365016
DIN 03365016 First appointment Jan 2011 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2011
Shareholding value •••• Premium profile

About Soumyabrata Das

Data last updated:

Soumyabrata Das is a Director at Gsr India Pharmaceuticals Private Limited (since 2011). The company operates in Chemicals. Gsr India Pharmaceuticals Private Limited reported revenue of ₹17 Lakh (FY 2018).

DIN 03365016
Primary Designation Director
Industry Chemicals
First Appointment 24 Jan 2011
Oldest Company Age 15 yrs
Largest company Gsr India Pharmaceuticals Private Limited · ₹17 Lakh (FY 2018)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Jan 20112011₹17 Lakh (FY 2018)Active

Board colleagues of Soumyabrata Das

Directorship timeline

Open interactive timeline →
Gsr India Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Soumyabrata Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Soumyabrata Das

Soumyabrata Das currently holds 1 directorship: Gsr India Pharmaceuticals Private Limited (Director, since 24 Jan 2011, revenue ₹17 Lakh (FY 2018)).

Soumyabrata Das was first appointed on 24 Jan 2011 as Director at Gsr India Pharmaceuticals Private Limited.

The current boards of Soumyabrata Das's companies include Gita Das (Gsr India Pharmaceuticals Private Limited), Rajeev Jain (Gsr India Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available